174 related articles for article (PubMed ID: 11062082)
1. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
[TBL] [Abstract][Full Text] [Related]
2. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
Gutfilen B; Fonseca LM
J Exp Clin Cancer Res; 2001 Sep; 20(3):385-91. PubMed ID: 11718219
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard.
Chen SL; Yin YQ; Chen JX; Sun XG; Xiu Y; Liu WG; Liu M; Zhu WM; Zhang YB
Anticancer Res; 1997; 17(3B):1695-8. PubMed ID: 9179221
[TBL] [Abstract][Full Text] [Related]
5. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C
Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472
[TBL] [Abstract][Full Text] [Related]
6. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
7. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.
Cutrone JA; Yospur LS; Khalkhali I; Tolmos J; Devito A; Diggles L; Vargas MP; Shitabata P; French S
J Nucl Med; 1998 Mar; 39(3):449-53. PubMed ID: 9529290
[TBL] [Abstract][Full Text] [Related]
8. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
Tiling R; Stephan K; Sommer H; Shabani N; Linke R; Hahn K
J Nucl Med; 2004 Nov; 45(11):1822-8. PubMed ID: 15534050
[TBL] [Abstract][Full Text] [Related]
10. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
Yildiz A; Colak T; Güngör F; Ozuğur S; Boz A; Tunçdemir F; Akaydin M
Rev Esp Med Nucl; 2001 Jun; 20(4):276-81. PubMed ID: 11440709
[TBL] [Abstract][Full Text] [Related]
12. [Breast scintigraphy with technetium 99m sestamibi, as support to radiologic methods in the study of breast lesions].
Occhiato R; Schillaci O; Broglia L; Danieli R; Narilli P; Pavone P; Scopinaro F; Passariello R
Radiol Med; 1996 May; 91(5):581-4. PubMed ID: 8693123
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
14. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Aziz A; Hashmi R; Ogawa Y; Hayashi K
Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
[TBL] [Abstract][Full Text] [Related]
15. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
16. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
[TBL] [Abstract][Full Text] [Related]
17. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
18. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between accumulation of (99m)Tc-MIBI in breast cancer or benign lesion, cell proliferation and angiogenesis].
Chen J; Yin Y; Chen S
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):553-5. PubMed ID: 11825464
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
